Sumitomo Mitsui Ds Asset Management Company, LTD Abb Vie Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $10.9 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 280,920 shares of ABBV stock, worth $55.6 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
280,920
Previous 272,830
2.97%
Holding current value
$55.6 Million
Previous $57.2 Million
8.78%
% of portfolio
0.48%
Previous 0.59%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
4,249Shares Held
1.27BCall Options Held
16.5MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA174MShares$34.4 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$27 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.8 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.8 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.15 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $350B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...